Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
EUR 45,76
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.35.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 63,10
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Lucky's Textbooks, Dallas, TX, USA
EUR 61,92
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: HPB-Red, Dallas, TX, USA
EUR 64,46
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Anbieter: California Books, Miami, FL, USA
EUR 69,55
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 70,68
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 65,39
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Books Puddle, New York, NY, USA
EUR 72,32
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New. 1 edition NO-PA16APR2015-KAP.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 65,84
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 70,13
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
EUR 75,41
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
Verlag: Chapman and Hall/CRC 2021-03-31, 2021
ISBN 10: 0367727072 ISBN 13: 9780367727079
Sprache: Englisch
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 69,32
Währung umrechnenAnzahl: 10 verfügbar
In den WarenkorbPaperback. Zustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 86,49
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 87,41
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 78,14
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 78,13
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 77,78
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Verlag: Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Sprache: Englisch
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 77,78
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 88,13
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Verlag: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Sprache: Englisch
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 120,12
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 94,11
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 442 pages. 9.21x6.14x1.10 inches. In Stock.
EUR 84,89
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbZustand: New.
Anbieter: Lucky's Textbooks, Dallas, TX, USA
EUR 139,35
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: California Books, Miami, FL, USA
EUR 156,71
Währung umrechnenAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 150,03
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Books Puddle, New York, NY, USA
EUR 162,30
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
EUR 169,46
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
Verlag: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Sprache: Englisch
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
EUR 113,23
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 166,89
Währung umrechnenAnzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: New. New. book.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 210,07
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 415 pages. 9.50x6.50x1.25 inches. In Stock.